HK Stock Market Move | JINHAI MED TECH (02225) rose nearly 8% in morning trading, with its Stock Connect shareholding ratio climbing rapidly and its revenue structure significantly optimized in the first half of the year.

JINHAI MED TECH (02225) rose nearly 8% in morning trading. As of press time, it was up 5.00% at HK$5.98, with a turnover of HK$15.3049 million. On the news front, on September 7, JINHAI MED TECH was officially included in the Stock Connect program. This inclusion helps broaden the shareholder base, attract long-term institutional investors, and enhance share trading liquidity. Data shows that northbound funds have recently been continuously increasing their holdings in JINHAI MED TECH, with the Stock Connect shareholding ratio rising rapidly from 0.3% on September 10 to 0.7% on September 18. It is worth noting that in the first half of the year, JINHAI MED TECH's revenue structure was significantly optimized. Revenue related to minimally invasive surgical solutions and medical products was S$25.43 million, a year-on-year surge of 301.5%, accounting for 74.73% of total revenue, and all of it came from the Chinese market. The financial report also shows that in the first half of the year, the company made a provision for China corporate income tax for the first time, meaning that JINHAI's China medical business has crossed the break-even line in operations.